Palantir Issues Additional Details About Life Sciences Capabilities to be Shown at “Double Click” on Wednesday, April 14, 2021

DENVER–()–Palantir Technologies (NYSE:PLTR) right now issued further particulars concerning the Palantir Foundry capabilities it is going to be highlighting in its Life Sciences demo at “Double Click” on Wednesday, April 14, 2021, at 11:00am ET.

Palantir’s prospects in Life Sciences span prescription drugs, analysis establishments, healthcare techniques, and others. These prospects depend on Foundry’s safe and collaborative structure to find and develop medication, handle industrial launches, conduct medical analysis, and distribute vaccines. For instance:

  • More than 1,000 researchers on the NIH’s National COVID Cohort Collaborative (N3C) use Foundry to securely keep one of many largest patient-level information property of COVID-19 Electronic Health Record (EHR) information on this planet and collaborate on greater than 150 analysis tasks (as illustrated on this video demonstration by N3C).
  • Thousands of General Practitioners at NHS England order, allocate, monitor, and ship each one of many 29+ million vaccines administered within the nation up to now (as outlined within the UK Government’s website for data and insights on COVID-19).

At the primary installment of Palantir’s Double Click series, engineers will demo the newest Foundry capabilities, in addition to a number of new Archetypes out there on prime of Foundry that make this work potential in a matter of clicks, together with:

  • Reproducible analysis in any surroundings. Foundry’s interoperable, modular, and open structure permits customers of various technical means to combine any information, use any instrument, handle any mannequin, and write code in any language — whereas sustaining end-to-end reproducibility, transparency, and safety of their analyses. Foundry integrates its governance and information administration capabilities with frequent information science environments comparable to RStudio or HPC clusters, enabling customers to work reproducibly with any libraries of their alternative — from specialised bioinformatics instruments comparable to plink to machine studying libraries comparable to scikit-learn, tensorflow, or MLlib.
  • Purpose-based entry controls. Foundry’s Purpose-Based Access Controls Archetype permits automated or managed project of permissions primarily based on the proposed use of a specific information supply or dataset. By systematically encoding information entry requests alongside the context of the related analysis, these entry controls present governance directors with granular perception into each evaluation a chunk of knowledge is used for, by whom, and for what motive.
  • Systematic mannequin administration. Foundry’s Model Management Archetype helps the governance and deployment of predictive fashions, together with these developed exterior Foundry. Researchers can readily reproduce outcomes, monitor how every model of a mannequin was developed, robotically replace fashions when upstream supply information modifications, examine efficiency metrics, and tag variations for launch into staging or manufacturing environments. Models will be deployed inside Foundry (batch or streaming, or API endpoint for ad-hoc querying) or to exterior techniques, together with specialised {hardware}. Health checks, telemetry, and wealthy mannequin monitoring of deployments assist organizations transcend mannequin drift to grasp and handle their fashions towards real-world eventualities.
  • Out of the field pipeline templates for standardized information fashions. Foundry’s Pipeline Archetype deploys pre-built information pipelines that convert frequent real-world information sources comparable to Optum claims or TriNetX into commonplace information fashions, comparable to OMOP. This permits researchers to simply pivot between sources, and reuse cohort code lists or analytic strategies which have already been outlined by the open-source group. For distinctive information sources, comparable to historic Randomized Controlled Trials, Foundry’s machine learning-powered Entity Resolution Archetype gives the framework for robotically suggesting mappings to a user-defined information mannequin and enabling human-driven affirmation.

For examples of analysis research and publications powered by Palantir Foundry, please see the record beneath.

About Palantir Double Click

Palantir software program is utilized by prospects throughout 40 industries worldwide. Double Click is Palantir’s collection of software program demo occasions that showcase how the corporate’s platforms are used throughout these industries and prospects.

Advance registration is required, and is obtainable at Capacity is restricted, and registration will shut 24 hours previous to the occasion. For extra data relating to the occasion, please go to or electronic mail

About Palantir Technologies Inc.

Palantir Technologies Inc. builds and deploys working techniques for the trendy enterprise. Additional data is obtainable at

Forward-Looking Statements

This press launch comprises forward-looking statements inside the that means of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements might relate to, however will not be restricted to, Palantir’s expectations relating to the occasion and the anticipated efficiency and advantages of, or anticipated updates to, its software program platforms. Forward-looking statements are inherently topic to dangers and uncertainties, a few of which can’t be predicted or quantified. Forward-looking statements are primarily based on data out there on the time these statements are made and have been primarily based on present expectations in addition to the beliefs and assumptions of administration as of that point with respect to future occasions. These statements are topic to dangers and uncertainties, lots of which contain elements or circumstances which might be past our management. These dangers and uncertainties embrace, however will not be restricted to, our means to satisfy the distinctive or anticipated wants of our prospects; the failure of our platforms to fulfill our prospects or carry out as desired; the frequency or severity of any software program and implementation errors; and our platforms’ reliability. Additional data relating to these and different dangers and uncertainties is included within the filings we make with the Securities and Exchange Commission every so often. Except as required by legislation, we don’t undertake any obligation to publicly replace or revise any forward-looking assertion, whether or not on account of new data, future developments, or in any other case.

Third-Party Websites and References

This press launch comprises hyperlinks to 3rd occasion web sites or data, that are supplied for informational functions solely and will not be integrated by reference herein. You are solely liable for your personal evaluation of such data and we make no representations as to their accuracy or completeness nor can we undertake to confirm or replace any such data. The inclusion of third occasion hyperlinks doesn’t represent endorsement by us of the linked web sites or any data or different linked data contained therein.

All third-party merchandise, publications, and names referenced herein are the property of their respective homeowners. Use of such references is for identification functions solely and doesn’t suggest any affiliation with or endorsement by such third-parties.

Select Publications Powered by Palantir Foundry


Please enter your comment!
Please enter your name here